Lucira Health Inc., a publicly traded maker of at-home Covid-19 tests, filed for Chapter 11 bankruptcy on Wednesday.
California-based Lucira listed assets of about $146 million and liabilities of about $85 million in its bankruptcy petition. The company will keep operating during bankruptcy as it seeks to sell itself, according to a statement.
Lucira sells an at-home Covid test that provides “lab-quality results” in 30 minutes, according to its website. A single test is listed for $35 on the site.
Declining Covid-19 restrictions crimped demand for the tests, squeezing Lucira, Chief Executive Officer Erik Engelson …